More on GTHP
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.20 |
|
|||
| Open | $0.20 | ||||
| 52 Wk High | $0.17 | ||||
| 52 Wk Low | $0.00 | ||||
| Day High | $0.20 | ||||
| Day Low | $0.20 | ||||
| P/E | N/A | ||||
| EPS | $-0.12 | ||||
| Volume | 2,046 | ||||
- GUIDED THERAPEUTICS files cervical cancer device clinical report with FDA
- Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA
- Form 10-Q GUIDED THERAPEUTICS INC For: Mar 31
- Form 4 GUIDED THERAPEUTICS INC For: Feb 25 Filed by: Blumberg Richard P.
- Form 4 GUIDED THERAPEUTICS INC For: Mar 10 Filed by: Grujic Alan
- Form 4 GUIDED THERAPEUTICS INC For: Mar 10 Filed by: Imhoff John E
- Form 4 GUIDED THERAPEUTICS INC For: Mar 10 Filed by: JAMES MICHAEL C
- Guided Therapeutics Provides Updates on FDA Application Study Results, 2025 Earnings Increase and Successful Warrant Offering
- Form 10-K GUIDED THERAPEUTICS INC For: Dec 31
- Form 4 GUIDED THERAPEUTICS INC For: Dec 18 Filed by: Imhoff John E
Entities mentioned with GTHP
- FDA | View Related Stories »
- S1 | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- NT 10-Q | View Related Stories »
- Dividend | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Show More...
